Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
about
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosisOral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against TuberculosisImplications of antibodies to pyruvylated glucose in healthy populations for mycobacterioses and other infectious diseasesEffect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccinationPreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisAnalysis of latent tuberculosis and mycobacterium avium infection data using mixture models.Persistence of the immune response induced by BCG vaccination.Monocyte antimycobacterial activity before and after Mycobacterium bovis BCG vaccination in Chingleput, India, and London, United Kingdom.Mycobacterium.Effectiveness of BCG vaccination to aged mice.Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.History of BCG Vaccine.Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination.Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.What has Karonga taught us? Tuberculosis studied over three decades.Mycobacterium avium in the postgenomic era.Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.Infections with atypical mycobacteria in British Columbia.Clinical and economic impact of a specific BCG vaccination program implemented in Prato, central Italy, involving foreign newborns on hospitalizations.The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?Sensitivity to tuberculin and to a nonmammalian sensitin in Mandalay District, Burma.Determining the prevalence of tuberculosis infection in populations with non-specific tuberculin sensitivity.Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area.A co-operative evaluation of test systems used to assay tuberculosis vaccines.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.Future policy for BCG vaccination in Britain.Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteriaCross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.The current state of tuberculosis vaccinesBoosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesImmunity to tuberculosis from the perspective of pathogenesis.Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India.Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.
P2860
Q24537176-8CFD915F-47D5-4AAD-A39C-A1867F22F25BQ27313927-C86E3981-65D0-403D-9021-7FAD35A21131Q28334799-92EDE9EC-5A59-4B02-B2F8-3C331F141767Q28350972-7DE7982E-B25D-4A17-BE5E-BB6D6E73A9BDQ28730427-EDA6F45C-FD42-42C7-8AFD-E6AEA703502CQ31063042-428B2FE3-5875-4DC0-8E40-C2BC91EA6076Q33316559-1697F6D8-2B59-403F-80B4-9E5AA7BDC92BQ33612595-8A8FCF29-4DDA-4783-A177-F50C362FE05BQ34072948-110491D4-8C70-4D47-AB97-5566ED886D8AQ34116842-0F6F2942-4C00-4954-B462-C1E4D750019EQ34179279-93CF44E5-0C2D-44B2-8407-B4F6E242ED56Q34370165-9C15CCA1-CA80-4862-8EE1-E8DC74710FC7Q34543090-53621BFA-1896-4C09-8EC2-AE9F0EFE403DQ34875651-06B83FB9-1CDF-48A9-93C2-207978B8733DQ35150762-063CFA16-740D-4274-B04B-555CEF050DA9Q35567441-86B5D9D3-06D7-4583-ACEC-871A601067F3Q35737870-35FA911C-8566-4F64-9ED0-740C11B79227Q35783445-B8FAE4D1-8D54-4272-8312-C2E6C99034D4Q35913675-AA4AD2A9-A955-4B88-80B1-34C9AFC68123Q35935549-D76E29D5-7BA3-4E82-8BA1-127102A9A163Q36019286-8EDC00A9-D2ED-4F10-94D1-C89FAC3C272EQ36565187-C630A301-8A60-48F2-AB26-FFDF46B3E8EBQ36629734-5BD8DF21-4EC2-461D-80EF-BFA7DDEFA4E3Q36675190-BD368E5A-06C4-43F0-AF71-9AFBB223B1BCQ36719361-D1A02A94-DE43-4644-818A-93334108E4E9Q36720683-A3DCC016-65B3-408A-9DD9-4966C166C9FEQ36736465-EC24F989-1A11-4E7C-A391-937885BA85FDQ36772073-1D7F936D-4046-4816-85EB-7E4E2C6DE624Q37080666-4442FDFB-0AC0-4DD7-9800-333973B6BAEFQ37410301-770FFFD7-EB7B-42EF-8D98-65971AABD5D4Q37426754-56F5FD60-7AD8-4C55-8F06-CD6D6137DD5AQ38116351-DAD603FE-8514-4146-80D9-58535DEF470EQ38447094-724E115B-91AD-4ED4-8D69-80E7A78B892EQ38529413-2CCB0667-76B6-4BBA-88C0-2A634EDBB354Q38711405-889C7BD0-7DB8-4A32-952D-538591C71366Q39552628-6B81335F-BD21-4D58-BDA9-4F5726DC7D69Q39585280-7559EE5F-A0AA-4CBD-B821-AF557D950208Q39585291-FFAB7D3D-1F8E-4FFF-9FCC-731936276C4AQ39915319-6D4AC88A-FBAD-4C3C-88D2-B90D8ED031FDQ39982362-D030855B-1929-4448-B4DC-52A7E07491D1
P2860
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh-hant
name
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@en
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@nl
type
label
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@en
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@nl
prefLabel
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@en
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@nl
P1476
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
@en
P2093
P304
P356
10.1164/ARRD.1966.94.4.553
P577
1966-10-01T00:00:00Z